Skip to main content

Table 7 Comparison of baseline CPG domain scores versus 6, 12 and 18 month visits. Values are expressed as median (range) with respective p values

From: A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain

 

Baseline

6 m

p

12 m

p

18 m

p

24 m

p

Pain intensity

66.6 (30–93)

39.9 (0–83.3)

0.001

30

(0–76.7)

<  0.001

30 (0–73.3)

p <  0.001

13.33

(0–36.3)

<  0.001

Disability

60

(16–113)

16.7 (0–93.3)

0.002

0 (0–66.7)

< 0.001

0 (0–63.3)

p < 0.001

0 (0–63)

0.001

Pain grade

3 (1–4)

1 (0–4)

0.004

0 (0–4)

0.001

0 (0–4)

p < 0.001

0 (0–4).

0.002

Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us